TXMD
NASDAQ · Pharmaceuticals
Therapeuticsmd Inc
$1.74
+0.03 (+1.75%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+582.8% upside
Low Target
$7.57
Average Target
$11.88
High Target
$17.16
Current Price
$1.74
Current
$1.74
$1.74
Target
$11.88
$11.88
$7.57
$11.88 avg
$17.16
Scenario Analysis
Bear Case
$7.57
335.1%
Low target
Base Case
$11.88
+582.8%
Avg target
Bull Case
$17.16
+886.2%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$2.95
-41.0% from high
52-Week Low
$1.11
+56.8% from low
Target vs 52W High
$11.88
+302.7% vs high
Next Earnings Report
Nov 10, 2026
2d
until earnings
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals